IL-6 was proved to be involved in tubulointerstitial fibrosis, tubular atrophy, acute and chronic lesions in immune renal diseases, like LN, in metabolic, ischemic, toxemic diseases [25,51]. Here, IL6 is linked to lobular neoplasia.